title: [Infected cholangiocarcinoma].
abstract: Cholangiocarcinomas are malignancies of the biliary duct system. They are encountered in 3 geographic regions: intrahepatic, proximal extrahepatic, and distal extrahepatic. The etiology of most bile duct cancers remains undetermined but some risk factors, like gallstone, have been suggested to play a role by inducing malignant transformation. The prognosis and clinical manifestations depend on the anatomical location and clinical presentation may be confuses or by means of complications like sepsis. We present a case of cholangiocarcinoma which made debut with cholestasis and sepsis in a cholecystectomiced patient, who had a long standing lithiasic cholecystitis.
authors.affiliation: Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza. raridru@mixmail.com
authors.forename: R
authors.initials: R
authors.lastname: Ridruejo Sáez
authors.forename: B
authors.initials: B
authors.lastname: Jiménez Bartolomé
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001344:Autopsy; D001650:Bile Duct Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy; D001653:Bile Ducts, Intrahepatic / Q000000981:diagnostic imaging* / Q000473:pathology; D018281:Cholangiocarcinoma / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy; D002763:Cholecystectomy; D002764:Cholecystitis / Q000150:complications* / Q000000981:diagnostic imaging / Q000601:surgery; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D011859:Radiography; D018805:Sepsis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents